Keywords: azur, launches, biosante, elestrin, usa, pharma, launched

Azur launches BioSante's Elestrin in USA

Article | 16 April 2009

Print This

The USA's Azur Pharma has launched Elestrin (estradiol gel). The firm licensed the treatment for the vasomotor symptoms associated with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in